市场调查报告书
商品编码
1347411
干细胞银行市场:2023-2028 年全球行业趋势、份额、规模、增长、机会和预测Stem Cell Banking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球干细胞银行市场规模达到74亿美元。展望未来,IMARC集团预计到2028年市场规模将达到117亿美元,2023-2028年復合年增长率(CAGR)为8.1%。
干细胞库是下一代干细胞疗法中最有前途也是增长最快的部分之一。这是提取、冷冻和储存干细胞以供未来使用的过程。获得干细胞的一些来源包括胚胎、脐带、脐带血、胎盘和骨髓。这些细胞用于治疗多种不同的疾病,包括糖尿病、地中海贫血、白血病、镰状细胞性贫血和心脏病。此外,它们还用于产生血小板、红细胞和白细胞。干细胞的再生潜力导致其在组织工程、基因治疗和再生医学中的应用。
儘管由于医学科学的进步,人类的平均预期寿命有所增加,但人类衰老仍然与多种疾病有关。因此,老年人口数量的增加将推动未来几年对干细胞治疗的需求。
发达地区和新兴地区的监管机构和非政府组织 (NGO) 正在采取倡议,向消费者灌输对干细胞治疗潜力的认识,从而影响干细胞银行市场的增长。
生育率的提高导致全球儿童数量的增加。这为保存含有造血(血液)干细胞的婴儿脐带提供了有利可图的机会。
促进市场增长的其他一些因素包括可支配收入的增加、干细胞研究临床试验的批准增加、慢性病患病率的增加和技术进步。
The global stem cell banking market size reached US$ 7.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.
Stem cell banking is one of the most promising as well as the fastest growing segment of the next-generation stem cell therapy. It is the process of extracting, freezing and storing stem cells for potential future use. Some of the sources through which stem cells are obtained include embryo, umbilical cord, cord blood, placenta and bone marrow. These cells are used for treating a number of different diseases including diabetes, thalassemia, leukemia, sickle cell anemia and cardiac diseases. Moreover, they are also employed for generating platelets, red blood cells and white blood cells. The potential of stem cells to regenerate has led to their applications in tissue engineering, gene therapy and regenerative medicines.
While the average human life expectancy has increased owing to the advancements in medical science, human aging is still associated with several diseases. Thus, the elevating count of geriatric population will drive the demand for stem cell therapy in the coming years.
Regulatory authorities as well as non-governmental organizations (NGO), across both developed and emerging regions, are taking initiatives for instilling awareness amongst consumers about the therapeutic potentials of stem cells, thereby influencing the stem cell banking market growth.
Increasing fertility rates has led to a rise in the number of children across the globe. This offers lucrative opportunities for preserving the umbilical cord of infants which contains hematopoietic (blood) stem cells.
Some of the other factors which are catalyzing the growth of the market include escalating disposable incomes, increasing approval of clinical trials in stem cell research, growing prevalence of chronic diseases and technological advancements.
IMARC Group provides an analysis of the key trends in each segment of the global stem cell banking market report, along with forecasts at the global and regional levels from 2023-2028. Our report has categorized the market based on product type, service type, bank type, utilization and application.
Adult Stem Cells
Human Embryonic Cells
IPS Cells
On the basis of product types, the market has been segmented as adult stem cells, human embryonic cells and IPS cells. Presently, adult stem cells account for the majority of the market share as they help in repairing damaged tissues via cell division. In addition to this, adult stem cells offer advantages like ease of harvesting, high acceptance in the human body and effectiveness in tissue generation.
Sample Preservation and Storage
Sample Analysis
Sample Processing
Sample Collection and Transportation
Based on service types, the market has been segmented as sample preservation and storage, sample analysis, sample processing, and sample collection and transportation.
Private
Public
Based on the bank type, the market has been segregated as private and public stem cell banks. Private stem cell banks currently dominate the market, holding the largest share.
Used
Unused
Based on the utilization, the market has been segregated as used and unused.
Personalized Banking Applications
Research Applications
Clinical Applications
On the basis of application, the market has been segmented as personalized banking applications, research applications and clinical applications.
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
On a geographical front, North America enjoys the leading position in the global stem cell banking market on account of advancements in medical infrastructure and availability of federal funding for stem cell research. Other regions include Europe, Asia Pacific, Middle East and Africa, and Latin America.
CBR Systems Inc.
China Cord Blood Corporation
Cordlife
Cordvida
Cryo-Cell International, Inc.
Cryo-Save AG (A Group of Esperite)
Cryoviva India
Lifecell
Smart Cells International Ltd
Viacord